Drug News

Stay up-to-date on the latest drug news. Learn about new drug approvals, labeling changes, expanded indications, recalls, and approvals of generic formulations. These drug news updates are compiled from the latest information from Facts & Comparisons® and the U.S. Food and Drug Administration.

(Updated August 12, 2019)

The FDA has approved the following drugs:
  • Clenpiq (sodium picosulfate/magnesium oxide/anhydrous citric acid) oral solution as a colon cleanser in preparation for colonoscopy in adults and pediatric patients 9 years and older. Clenpiq was previously approved for adults only. 
  • Turalio (pexidartinib) oral capsules to treat adult patients with symptomatic tenosynovial giant cell tumor associated with severe morbidity or functional limitations and not amenable to improvement with surgery. A major risk includes hepatotoxicity.
The FDA has approved the following expanded indications:
  • Enstilar (calcipotriene/betamethasone dipropionate) topical foam to treat plaque psoriasis in patients 12 years and older. Enstilar foam was previously approved for patients 18 years and older.
The FDA has approved the following Boxed Warning:
  • Edluar (zolpidem tartrate) sublingual tablets regarding the risk of complex sleep behaviors (eg, sleepwalking, sleep-driving). Edluar is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. 

More Nursing News Headlines (Pharmacy)...

Powered by